You are here

• Home
• Therapy Areas
• Oncology/Infection

• A Phase-1, Single Center, Double Blind, Randomized, Placebo-controlled, Parallel-group Study to assess the Safety, Tolerability and Pharmacokinetics of Intravenous AZD9742 after Single Ascending Doses in Healthy Male and Female Subjects

Disease

MRSA, pneumonia

Drug Name

AZD9742

Generic Name

AZD9742

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

Nov 30, 2009

Study Name

D2690C00001

Study Id

D2690C00001

ClinicalTrials.gov ID

NCT01030224

Recruiting Status

Closed

Protocol Status

Not Available

Report

Sep 28, 2010

• D2690C00001_A.pdf (165 KB)

Page tools

• Print
• Bookmark this page